Citation Impact

Citing Papers

Review article: the global emergence of Helicobacter pylori antibiotic resistance
2015
Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter
2013
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial
2016
Microbiota in health and diseases
2022 Standout
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
2015
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
2021 Standout
Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
2017
Colonic bacterial metabolites and human health
2013
Discovery and quantification of plastic particle pollution in human blood
2022 Standout
Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer
2013
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Mechanisms of hepatic stellate cell activation
2017 Standout
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma
2019 StandoutNobel
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
2015 Standout
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Gut biogeography of the bacterial microbiota
2015 Standout
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
2016
Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study
2014
Systematic review with meta‐analysis: the efficacy of levofloxacin triple therapy as the first‐ or second‐line treatments of Helicobacter pylori infection
2016
Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
2017
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients
2014
The role of the gut microbiota in nutrition and health
2012 Standout
Reprogramming Cellular Identity for Regenerative Medicine
2012
Pathophysiology of NASH: Perspectives for a Targeted Treatment
2013
Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis
2015
Irritable bowel syndrome
2016 Standout
The complex microbiota of raw milk
2013 Standout
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
2018
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
2015
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
2017
Polystyrene microplastics induce gut microbiota dysbiosis and hepatic lipid metabolism disorder in mice
2018
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
2014
Pyroptosis: mechanisms and diseases
2021 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
The role of the gut microbiota in NAFLD
2016
The Gordian Knot of dysbiosis, obesity and NAFLD
2013
Helicobacter pyloriand the molecular pathogenesis of intestinal-type gastric carcinoma
2014
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis
2015
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
2013
The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
2018
Accuracy of GastroPanel for the diagnosis of atrophic gastritis
2014
Milk Fermented by Propionibacterium freudenreichii Induces Apoptosis of HGT-1 Human Gastric Cancer Cells
2012
Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
2015
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
2013
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Dysbiosis of the gut microbiota in disease
2015 Standout
EMT: 2016
2016 Standout
Gut microbiota and Covid-19- possible link and implications
2020 Standout
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities
2012
Gastric cancer
2020 Standout
Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in First-Degree Relatives of Gastric Cancer Patients Compared with Age-Sex Matched Controls
2013
Review of antibiotic resistance in China and its environment
2017 Standout
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial
2018
Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
2013
DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer
2014
Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study
2013
Altered Expression of Hypoxia-Inducible Factor-1α (HIF-1α) and Its Regulatory Genes in Gastric Cancer Tissues
2014
Bacillus amyloliquefaciens SC06 Protects Mice Against High-Fat Diet-Induced Obesity and Liver Injury via Regulating Host Metabolism and Gut Microbiota
2019
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use
2015
NAFLD: A multisystem disease
2015 Standout
Value of gastrin-17 in detecting antral atrophy
2011
Gut microbiota and non-alcoholic fatty liver disease: new insights
2013
Modeling Development and Disease with Organoids
2016 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
Intestinal microbiota in functional bowel disorders: a Rome foundation report
2012
Irritable Bowel Syndrome
2015 Standout
Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis
2014
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
2016
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
2014
The role of gut microbiota in the pathogenesis of colorectal cancer
2013
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Meta-Analysis of Sequential, Concomitant and Hybrid Therapy for <i>Helicobacter pylori</i> Eradication
2015
Lipotoxicity and the gut-liver axis in NASH pathogenesis
2017
Primary antibiotic resistance ofHelicobacter pyloristrains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study
2015
Clinical Evaluation of a Ten‐Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication of Helicobacter pylori in a High Clarithromycin Resistance Area
2013
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
2013
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
2015 Standout
Postbiotics: An evolving term within the functional foods field
2018
Postbiotics: facts and open questions. A position paper on the need for a consensus definition
2019
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Mediterranean Diet and Health: Food Effects on Gut Microbiota and Disease Control
2014
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
2020 Standout
Gut microbiome and aging: Physiological and mechanistic insights
2017

Works of Debora Compare being referenced

Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome
2017
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy
2005
CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors
2011
Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis
2011
Contribution of Gut Microbiota to Colonic and Extracolonic Cancer Development
2011
<i>Helicobacter pylori</i> and Epigenetic Mechanisms Underlying Gastric Carcinogenesis
2007
Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
2012
Effects of long-term PPI treatment on producing bowel symptoms and SIBO
2010
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection
2012
The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
2016
Protective effects ofLactobacillus paracaseiF19 in a rat model of oxidative and metabolic hepatic injury
2010
Risk factors in gastric cancer.
2010
Rankless by CCL
2026